Targeting CXCR2 signaling inhibits KRAS(G12D) induced autocrine growth transformation by suppressing ERK activation in pancreatic cancer

被引：0
|
作者：
Purohit, Abhilasha [1 ]
Varney, Michelle [1 ]
Rachagani, Satya [1 ]
Myneni, Pavan [1 ]
Ouellette, Michel [1 ]
Batra, Surinder K. [1 ]
Singh, Rakesh K. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3178
引用
收藏
页数：1
相关论文
共 19 条
  • [1] CXCR2 signaling regulates KRAS(G12D)-induced autocrine growth of pancreatic cancer
    Purohit, Abhilasha
    Varney, Michelle
    Rachagani, Satyanarayana
    Ouellette, Michel M.
    Batra, Surinder K.
    Singh, Rakesh K.
    ONCOTARGET, 2016, 7 (06) : 7280 - 7296
  • [2] CXCR2 signaling axis- a helping hand to KRAS(G12D) mutation in pancreatic cancer initiation
    Purohit, Abhilasha
    Varney, Michelle
    Rachagani, Satya
    Ouellette, Michel
    Batra, Surinder K.
    Singh, Rakesh K.
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer
    Huang, Ri
    Du, Hong
    Cheng, Liang
    Zhang, Peizhuo
    Meng, Fenghua
    Zhong, Zhiyuan
    ACTA BIOMATERIALIA, 2023, 168 : 529 - 539
  • [4] Pancreatitis promotes oncogenic Kras(G12D)-induced pancreatic transformation through activation of Nupr1
    Grasso, Daniel
    Garcia, Maria Noe
    Hamidi, Tewfik
    Cano, Carla
    Calvo, Ezequiel
    Lomberk, Gwen
    Urrutia, Raul
    Iovanna, Juan L.
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (01)
  • [5] KRAS G12D and G12V specific alkylating agent (KR12) inhibits growth of colon cancer with those KRAS mutations in vitro as well as in vivo
    Nagase, Hiroki
    Hiraoka, Kiriko
    Inoue, Takahiro
    Watanabe, Takayoshi
    Shinohara, Ken-Ichi
    Koshikawa, Nobuko
    Toshinori, Ozaki
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma
    Maeda, Shintaro
    Kuboki, Satoshi
    Nojima, Hiroyuki
    Shimizu, Hiroaki
    Yoshitomi, Hideyuki
    Furukawa, Katsunori
    Miyazaki, Masaru
    Ohtsuka, Masayuki
    CYTOKINE, 2017, 95 : 12 - 21
  • [7] Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors
    Kazi, Aslamuzzaman
    Ranjan, Alok
    Kumar, Vasantha M. V.
    Agianian, Bogos
    Chavez, Martin Garcia
    Vudatha, Vignesh
    Wang, Rui
    Vangipurapu, Rajanikanth
    Chen, Liwei
    Kennedy, Perry
    Subramanian, Karthikeyan
    Quirke, Jonathan C. K.
    Beato, Francisca
    Underwood, Patrick W.
    Fleming, Jason B.
    Trevino, Jose
    Hergenrother, Paul J.
    Gavathiotis, Evripidis
    Sebti, Said M.
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (12): : 2623 - 2639
  • [8] Enhancing KRAS G12D inhibitor sensitivity in pancreatic cancer through SHP2/PI3K pathway
    Hao, Man-Wei
    Zhang, Tian-Xing
    Dong, Dan
    Zhou, Xin
    Gao, Haicheng
    MEDICAL ONCOLOGY, 2025, 42 (05)
  • [9] KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H2S axis and contributes to pancreatic cancer growth
    Fan, Kun
    Zhang, Shulong
    Ni, Xiaojian
    Shen, Sheng
    Wang, Jiwen
    Sun, Wentao
    Suo, Tao
    Liu, Han
    Ni, Xiaoling
    Liu, Houbao
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (11) : 1731 - 1739
  • [10] Cordycepin inhibits pancreatic cancer cell growth in vitro and in vivo via targeting FGFR2 and blocking ERK signaling
    Li Xue-Ying
    Tao Hong
    Jin Can
    Du Zhen-Yun
    Liao Wen-Feng
    Tang Qing-Jiu
    Ding Kan
    CHINESE JOURNAL OF NATURAL MEDICINES, 2020, 18 (05) : 345 - 355
12